AbbVie gets FDA approval for Hepatitis C combination therapy

AbbVie gets FDA approval for Hepatitis C combination therapy
Daklinza plus sofosbuvir resulted in 90% SVR12 in treatment-naive and 86% in treatment-experienced chronic HCV genotype 3 patients. Most people infected with HCV have no symptoms of the disease until liver damage becomes apparent, which may take …
Read more here.

As Heroin Use Increases, Newborns Pay Price
Most have hepatitis C. Opiates are now the favored drug for about 75 percent of the women, Jansson said, but they are often mixed with cocaine, marijuana and alcohol. Virtually every … Some newborns experience only mild symptoms. Researchers are …
Read more here.

Supplement Use Leads to First-of-Its-Kind Hepatitis Case in US
Serology results for hepatitis A, hepatitis B, and hepatitis C were negative and a liver biopsy showed increase in sinusoidal macrophages and lymphocytes in the lobules. Most portal areas showed small number of eosinophils and macrophages and no …
Read more here.

Hepatitis – The Silent Epidemic
According to the Centers for Disease Control and Prevention (CDC), approximately 3.2 million Americans have chronic hepatitis C virus (HCV) and another 1.2 million have chronic hepatitis B virus (HBV). Hepatitis B and C are spread primarily … Known …
Read more here.

Sleep Physician Sees Patients for Massachusetts Medical Marijuana Program
With more than 25 years experience in patient care, Weiner focuses on the patient's chronic or debilitating conditions and accompanying symptoms such as pain, fatigue, nausea, hypersomnia, and insomnia. … Effective January 2013, all patients …
Read more here.

EDITORIAL: Diane Parsons Forsyth was tenacity personified
We have many reasons to honour Diane Forsyth, the brave, humble and tenacious Halifax woman who gave much of her life and strength to fight for proper care and compensation for thousands of Canadians who contracted hepatitis C from tainted blood in the …
Read more here.


Leave a Reply